Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT04034173
Title Optimal Anti-EGFR Treatment of mCRC Patients With Low-Frequency RAS Mutation
Recruitment Not yet recruiting
Gender both
Phase Phase II
Variant Requirements Yes
Sponsors Ludwig-Maximilians - University of Munich
Indications

colon adenocarcinoma

rectum adenocarcinoma

Therapies

Fluorouracil + Irinotecan + Leucovorin + Panitumumab

Age Groups: adult | senior
Covered Countries

Additional content available in CKB BOOST